Surfactants: Their Critical Role in Enhancing Drug Delivery to the Lungs
- 16 May 2011
- journal article
- review article
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 2 (5) , 623-641
Abstract
For local lung conditions and diseases, pulmonary drug delivery has been widely used for more than 50 years now. A more recent trend involves the pulmonary route as a systemic drug-delivery target....Keywords
This publication has 105 references indexed in Scilit:
- Engineering gas-foamed large porous particles for efficient local delivery of macromolecules to the lungEuropean Journal of Pharmaceutical Sciences, 2010
- Formulation strategy and use of excipients in pulmonary drug deliveryInternational Journal of Pharmaceutics, 2010
- Inhalable large porous microspheres of low molecular weight heparin: In vitro and in vivo evaluationJournal of Controlled Release, 2008
- In Vitro / In Vivo Comparisons in Pulmonary Drug DeliveryJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2008
- The rejuvenated pressurised metered dose inhalerExpert Opinion on Drug Delivery, 2007
- Rapid transport of large polymeric nanoparticles in fresh undiluted human mucusProceedings of the National Academy of Sciences, 2007
- Absorption of water-soluble compounds with different molecular weights and [Asu1.7]-eel calcitonin from various mucosal administration sitesJournal of Controlled Release, 2001
- Inhalation of Estradiol for Sustained Systemic DeliveryJournal of Aerosol Medicine, 1999
- Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Dilution of nebulised aerosols by air entrainment in childrenThe Lancet, 1990